2001Drug Delivery SystemOpen access

Clinical applications of monoclonal antibody therapy.

Chikako Shimizu, Yasuhiro Matsumura

Open full text 0 citations

Abstract

The recent development of humanized monoclonal antibody has made antibody therapy, which has many theoretical attractions, an encouraging choice of treatment in hematology/oncology area. This article reviews the basic theory and clinical applications of major antibody therapy, including Herceptin, Rituxan and other antibodies of interest.

Open-access reader

About this research paper

What this paper is about

The recent development of humanized monoclonal antibody has made antibody therapy, which has many theoretical attractions, an encouraging choice of treatment in hematology/oncology area. This article reviews the basic theory and clinical applications of major antibody therapy, including Herceptin, Rituxan and other antibodies of interest.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The recent development of humanized monoclonal antibody has made antibody therapy, which has many theoretical attractions, an encouraging choice of treatment in hematology/oncology area. This article reviews the basic theory and clinical applications of major antibody therapy, including Herceptin, Rituxan and other antibodies of interest.

Key concepts: Monoclonal antibody, Antibody therapy, Monoclonal antibody therapy, Medicine, Antibody, Hematology, Oncology, Bispecific antibody

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical applications of monoclonal antibody therapy. — Research Paper | ScholarLens